comparemela.com
Home
Live Updates
BenevolentAI progresses BEN-34712 for ALS treatment : comparemela.com
BenevolentAI progresses BEN-34712 for ALS treatment
BenevolentAI, a clinical-stage AI development company, has announced the successful delivery of its pre-clinical candidate for the potential treatment of amyotrophic lateral sclerosis (ALS), BEN-34712.
Related Keywords
,
Richard Mead
,
Anne Phelan
,
Sheffield Institute For Translational Neuroscience Sitra
,
University Of Sheffield
,
Sheffield Institute
,
Translational Neuroscience
,
Bio Developments
,
Hi
,
Artificial Intelligence
,
Clinical Trials
,
Drug Discovery
,
comparemela.com © 2020. All Rights Reserved.